LENZ Stock Analysis: Buy, Sell, or Hold?
LENZ - LENZ Therapeutics, Inc. Common Stock
$6.15
-0.19 (-3.00%)
▼
5d:
-5.38%
30d:
-7.52%
90d:
-46.48%
HOLD
LOW Confidence
Analysis Updated: Jun 18, 2026 12:00 AM ET
Earnings: Jul 29, 2026
Get Alerted When LENZ Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: LENZ shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: LENZ shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: LENZ is currently trading at $6.15, which is considered oversold relative to its 30-day fair value range of $6.57 to $7.55.
Technical Outlook: Technically, LENZ is in a strong downtrend. Immediate support is located at $5.84, while resistance sits at $7.36.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $32.00 (+420.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LENZ is in a strong downtrend. Immediate support is located at $5.84, while resistance sits at $7.36.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $32.00 (+420.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$6.57 -
$7.55
Company Quality Score
37/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 420.3% below Wall St target ($32.00)
- CAUTION: Recommendation downgraded due to -5.4% 5-day decline
Trading Range Analysis
30-Day Trading Range
$6.57 -
$7.55
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$5.84
Resistance Level
$7.36
Current Trend
Strong Downtrend
Technical data as of
Jun 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.77
Wall Street Target
$32.00
(+420.3%)
Share & Embed Analysis
Last updated: June 22, 2026 9:25 AM ET
Data refreshes hourly during market hours. Next update: 10:25 AM
Data refreshes hourly during market hours. Next update: 10:25 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LENZ showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 67 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 59 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 61 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 67 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 54 HOLD |
